Projects per year
Personal profile
Area of Expertise
Pre-Clinical Services evaluate new therapies against infections using animal models. These studies are done in collaboration with pharmaceutical and academic researchers, and several of these therapies are now being used clinically to treat patients.
Education/Academic qualification
PhD in Microbiology, University of Alabama
BS in Biology, University of California at Irvine
Fingerprint
Dive into the research topics where Jerry Simecka is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Texas Center of Minority Health, Education, Research and Outreach - Admin/Development Core
Vishwanatha, J., Jones, H., He, J., Basha, R., Nandy, K., Mallet, R., Krishnamoorthy, R. & Simecka, J.
NIMHD: Natl Institute on Minority Health
23/09/17 → 31/05/22
Project: Research
-
Development and Validation of a Chronic Murine Lung Infection Model with S. Aureus
17/10/19 → 16/10/20
Project: Research
-
Pre-Clinical Services Agreements
Pre-Clinical Services Funding Pool
1/09/19 → 31/08/20
Project: Research
-
Development and Validation of a Chronic Murine Lung Infection Model with P. aeruginosa
18/04/19 → 17/04/20
Project: Research
-
Epidemic ribotypes of Clostridium (now Clostridioides) difficile are likely to be more virulent than non-epidemic ribotypes in animal models
Vitucci, J. C., Pulse, M., Tabor-Simecka, L. & Simecka, J., 5 Feb 2020, In: BMC Microbiology. 20, 1, 27.Research output: Contribution to journal › Article › peer-review
Open Access -
Clotam enhances anti-proliferative effect of vincristine in Ewing sarcoma cells
Shelake, S., Sankpal, U. T., Eslin, D., Bowman, W. P., Simecka, J. W., Raut, S., Ray, A. & Basha, R., 15 Feb 2019, In: Apoptosis. 24, 1-2, p. 21-32 12 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Copper-tolfenamic acid: evaluation of stability and anti-cancer activity
Hurtado, M., Sankpal, U. T., Chhabra, J., Brown, D. T., Maram, R., Patel, R., Gurung, R. K., Simecka, J., Holder, A. A. & Basha, R., 15 Feb 2019, In: Investigational New Drugs. 37, 1, p. 27-34 8 p.Research output: Contribution to journal › Article › peer-review
7 Scopus citations -
Primary care clinics can be a source of exposure to virulent Clostridium (now Clostridioides) difficile: An environmental screening study of hospitals and clinics in Dallas-Fort Worth region
Simecka, J. W., Fulda, K. G., Pulse, M., Lee, J. H., Vitucci, J., Nguyen, P., Taylor, P., Filipetto, F., Espinoza, A. M. & Sharma, S., 1 Aug 2019, In: PLoS ONE. 14, 8, e0220646.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Activity of meropenem-vaborbactam against carbapenem- resistant enterobacteriaceae in a murine model of pyelonephritis
Weiss, W. J., Pulse, M. E., Nguyen, P., Peterson, K., Silva, J., Simecka, J. W., Valtierra, D., Sabet, M. & Griffith, D. C., Jan 2018, In: Antimicrobial agents and chemotherapy. 62, 1, e01439.Research output: Contribution to journal › Article › peer-review
11 Scopus citations